Gestational Diabetes Mellitus
Metabolic Diseases
5
Pipeline Programs
3
Companies
4
Clinical Trials
2
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
4
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Peptide
1100%
+ 3 programs with unclassified modality
On Market (2)
Approved therapies currently available
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Novo NordiskBAGSVAERD DENMARK, Denmark
3 programs1
2
LiraglutidePhase 4Peptide1 trial
MetforminPhase 41 trial
Metformin XR plus placeboPhase 31 trial
Active Trials
Eli Lilly and CompanyINDIANAPOLIS, IN
1 programGestational Diabetes Mellitus and Cardiometabolic Syndrome in OffspringN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Novo NordiskMetformin
Novo NordiskLiraglutide
Novo NordiskMetformin XR plus placebo
Eli Lilly and CompanyGestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring
Clinical Trials (4)
Total enrollment: 411 patients across 4 trials
Preventing Recurrent Gestational Diabetes With Metformin
Start: Jan 2015Est. completion: Sep 2019112 patients
Phase 4Unknown
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
Start: Jul 2012Est. completion: Sep 2020105 patients
Phase 4Completed
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Start: Aug 2011Est. completion: Jun 2019153 patients
Phase 3Completed
NCT01490372Eli Lilly and CompanyGestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring
Gestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring
Start: Aug 2011Est. completion: May 201341 patients
N/ACompleted
Related Jobs in Metabolic Diseases
Manager, Patient Safety and Pharmacovigilance Operations
Kailera Therapeutics
Waltham, Massachusetts
8h ago
Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV
Amgen
California - San Francisco, US
Yesterday
(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)
Johnson & Johnson
Beerse, Antwerp, Belgium
2d ago
Computational Chemist
Topos Bio
San Francisco Office
2d ago
Associate Director, Legal Operations & Contracts Management
Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr
Application & Integration Architect
Roche
Indianapolis
5d ago
$106K - $196K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space